Hyperproliferative diseases such as Chronic Lymphocytic Leukemia (CLL) and Systemic Lupus Erythematosus (SLE) are potentially related to some disturbance in the apoptosis pathway, specifically in B-1a cells (CD5<sup>+</sup>). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.